Treace Medical Concepts, Inc. (TMCI) Misses Q3 EPS by 2c

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q3 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $40.8 million versus the consensus estimate of $42.11 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• Nike (NKE) Tops Q1 EPS by 4c
• Brady sells French first-aid unit Securimed for ~$59 million
• Raymond James Updates Healthcare Top Picks for October